THE BIG SALE IS ON! TELL ME MORE

Close Notification

Your cart does not contain any items

$152.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
16 July 2015
Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector.

The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver).

The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer.

Edited by:  
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm,  Spine: 43mm
Weight:   1.720kg
ISBN:   9780128002063
ISBN 10:   0128002069
Series:   Translational Epigenetics
Pages:   748
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Replaced By:   9780323913676
Format:   Hardback
Publisher's Status:   Active

Steven Gray is a Senior Clinical Scientist and Adjunct Assistant Professor in the Thoracic Oncology Research Group, Trinity Centre for Health Sciences at St. James's Hospital, Dublin, Ireland.

Reviews for Epigenetic Cancer Therapy

...a helpful reference for researchers and medical professionals interested in epigenetics...contains many resources that may be useful for readers or guide them to technologies and areas of interest quickly. Score: 84 - 3 Stars --Doody's, Epigenetic Cancer Therapy


See Also